A Double-Blind, Parallel, Randomized Comparison of Two Doses of MitoQ [mitoquinone] and Placebo for the Treatment of Patients With Raised Liver Enzymes Due to Hepatitis C
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2010
At a glance
- Drugs Mitoquinone (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Antipodean Pharmaceuticals
- 24 Apr 2008 The primary endpoint and other results have been reported in an Antipodean Pharmaceuticals media release.
- 14 Apr 2008 New trial record.
- 10 Apr 2008 Results will be presented at the EASL annual meeting in April 2008.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History